<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               7 DRUG INTERACTIONS<BR>               <BR>                  <BR>                     <BR>                        Tamoxifen <BR>                     <BR>                  <BR>                  Coadministration of letrozole and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels of 38% on average. Clinical experience in the second-line breast cancer trials indicates that the therapeutic effect of letrozole therapy is not impaired if letrozole is administered immediately after tamoxifen. <BR>                  <BR>                     <BR>                        Cimetidine <BR>                     <BR>                  <BR>                  A pharmacokinetic interaction study with cimetidine showed no clinically significant effect on letrozole pharmacokinetics. <BR>                  <BR>                     <BR>                        Warfarin <BR>                     <BR>                  <BR>                  An interaction study with warfarin showed no clinically significant effect of letrozole on warfarin pharmacokinetics. <BR>                  <BR>                     <BR>                        Other anticancer agents <BR>                     <BR>                  <BR>                  There is no clinical experience to date on the use of letrozole in combination with other anticancer agents. <BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>